Fumaric acid esters in psoriasis and multiple sclerosis

C Zecca1, M Caporro, M Adami

  • 1Department of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale, Lugano, Switzerland.

Insights

Fumaric acid esters (FAEs) effectively treated severe plaque psoriasis in a multiple sclerosis (MS) patient unresponsive to other therapies. This suggests FAEs may benefit MS patients with treatment-induced psoriasis.

Area of Science:

  • Dermatology and Neurology
  • Immunomodulatory Therapies

Background:

  • Psoriasis and multiple sclerosis (MS) are chronic inflammatory conditions.
  • Fumaric acid esters (FAEs) and dimethylfumarate show efficacy in psoriasis and MS, respectively.
  • Immune-modulating agents, like interferon-β-1a, can induce or exacerbate psoriasis.

Observation:

  • A patient with MS developed severe plaque psoriasis during interferon-β-1a therapy.
  • The patient's psoriasis was refractory to topical treatments and phototherapy.
  • Dimethylfumarate (a component of FAEs) is used for relapsing MS.

Findings:

  • The patient received FAEs at 720 mg daily.
  • Complete remission of psoriatic lesions was observed.
  • Neurological stabilization was maintained over 24 months of follow-up.

Implications:

  • FAEs may be a viable treatment option for plaque psoriasis in MS patients.
  • This approach could be particularly useful for psoriasis induced by immune-modulating agents.
  • Further research into FAEs for managing comorbidities in MS is warranted.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Carboxylic Acids to Esters: Acid-Catalyzed (Fischer) Esterification Overview01:20

Carboxylic Acids to Esters: Acid-Catalyzed (Fischer) Esterification Overview

The Fischer esterification reaction was developed by the German chemist Emil Fischer in 1895. It is a condensation reaction between carboxylic acids and alcohols in an acidic medium to give esters and water.
15.1K
Carboxylic Acids to Esters: Acid-Catalyzed (Fischer) Esterification Mechanism01:13

Carboxylic Acids to Esters: Acid-Catalyzed (Fischer) Esterification Mechanism

Carboxylic acids react with alcohols to yield esters via an acid-catalyzed condensation reaction called Fischer esterification. This is a nucleophilic acyl substitution reaction that proceeds via a tetrahedral intermediate, where a water molecule is eliminated as the leaving group.
9.1K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
705
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
6.4K